carmustine has been researched along with sodium selenite in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benathan, M | 1 |
| Bhamre, S; Cohen, HJ; Nuzzo, RL; Olshen, RA; Whitin, JC | 1 |
| Menon, M; Thamilselvan, S; Thamilselvan, V | 1 |
3 other study(ies) available for carmustine and sodium selenite
| Article | Year |
|---|---|
Opposite regulation of tyrosinase and glutathione peroxidase by intracellular thiols in human melanoma cells.
Topics: Buthionine Sulfoximine; Carmustine; Cysteine; Cystine; Glutathione; Glutathione Peroxidase; Humans; Melanins; Melanoma; Monophenol Monooxygenase; Oxidative Stress; Sodium Selenite; Sulfhydryl Compounds; Tumor Cells, Cultured | 1997 |
Intracellular reduction of selenite into glutathione peroxidase. Evidence for involvement of NADPH and not glutathione as the reductant.
Topics: Animals; Buthionine Sulfoximine; Carmustine; Cell Line; Cricetinae; Enzyme Inhibitors; Glucosephosphate Dehydrogenase; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Humans; Male; Methylene Blue; NADP; Oxidation-Reduction; Sodium Selenite; Tumor Cells, Cultured | 2000 |
Combination of carmustine and selenite effectively inhibits tumor growth by targeting androgen receptor, androgen receptor-variants, and Akt in preclinical models: New hope for patients with castration resistant prostate cancer.
Topics: Androgen Receptor Antagonists; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carmustine; Cell Line, Tumor; Cell Proliferation; Humans; Male; Mice; Mice, Nude; Molecular Targeted Therapy; Prostatic Neoplasms, Castration-Resistant; Proto-Oncogene Proteins c-akt; Receptors, Androgen; Signal Transduction; Sodium Selenite; Xenograft Model Antitumor Assays | 2016 |